No Detail Found!

Evaluation of Calciferol, Cobalamin, and Stromelysin-1 in Patients with Diabetic Peripheral Neuropathy due to Type-2 Diabetes Mellitus

Author(s)
Bulent Bilir Department of Internal Medicine, Namik Kemal University School of Medicine,Tekirdag,Turkey
Ibrahim Yilmaz Unit of Pharmacovigilance, Republic of Turkey, Ministry of Health, Doctor Ismail Fehmi Cumalioglu City Hospital,Tekirdag,Turkey
Numan Karaarsalan Department of Neurosurgery, Halic University School of Medicine,Istanbul,Turkey
Betul Ekiz Bilir Department of Endocrinology and Metabolic Diseases, Republic of Turkey, Ministry of Health, Doctor Ismail Fehmi Cumalioglu City Hospital,Tekirdag,Turkey
Necati Kaplan Department of Neurosurgery, Istanbul Rumeli University, Corlu Reyap Hospital,Tekirdag,Turkey
Hane Ozbek Department of Medical Pharmacology, Izmir Bakircay University School of Medicine,Izmir,Turkey
Abstract
Objective: To evaluate the relationship between calciferol (vitamin D), cobalamin (vitamin-B12), and Stromelysin-1 (MMP-3) circulating levels in patients with diabetic peripheral neuropathy (DPN), patients with DM type 2 (T2DM) without neuropathy, and healthy control groups. Study Design: Cross-sectional descriptive study. Place and Duration of Study: Department of Internal Medicine, Namik Kemal University of Medicine, Tekirdag, Turkey, between November 2020 and February 2022. Methodology: Healthy, age, and gender matched volunteers who were admitted to the hospital for a check-up with no health problem constituted the control group (n=30). Cases diagnosed with T2DM (n=30) and those with DPN (n=30) comprised the experimental group. Stromelysin-1, calciferol, and cobalamin levels were analysed from blood samples from all groups using enzyme-linked immunosorbent assay (ELISA) with a commercial kit. Tukey's Honest Signi cant Di erence (HSD) test was performed after one-way analysis of variance (ANOVA) for intergroup comparisons. Alpha signi cance level was accepted as <0.05. Results: There were signi cant di erences in terms of the stromelysin-1, calciferol, and cobalamin levels of both the T2DM and DPN groups compared to healthy volunteers. These di erences were statistically signi cant (p=0.00). There was a very weak negative correlation between stromelysin-1 and calciferol (p=0.972, r=-0.007) and a weak negative correlation between cobalamin and stromelysin-1 (p=0.062, r=-0.345) in DPN patients, without statistical signi cance. Conclusion: Serum stromelysin-1 expression may be related to DPN progression in diabetic patients and may be a potential marker in DPN. Calciferol and cobalamin levels may also be important in the development of DPN.
Publication Details
Page(s) 1255-1259
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 10, Year: 2022

Request the full text from PASTIC

Keywords
Calciferol, cobalamin, Diabetic peripheral neuropathy, Stromelysin-1
0

Citations

0

Downloads

48

Views